|
|
Volumn 30, Issue 5, 2012, Pages 377-379
|
|
Affymax poised to challenge Amgen.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ERYTHROPOIETIN;
PEGINESATIDE;
PEPTIDE;
RECOMBINANT ERYTHROPOIETIN;
RECOMBINANT PROTEIN;
ANEMIA;
BIOTECHNOLOGY;
CHEMISTRY;
COMMERCIAL PHENOMENA;
ERYTHROPOIESIS;
HUMAN;
METHODOLOGY;
NOTE;
PATENT;
PHYSIOLOGY;
UNITED STATES;
ANEMIA;
BIOTECHNOLOGY;
COMMERCE;
ERYTHROPOIESIS;
ERYTHROPOIETIN;
HUMANS;
PATENTS AS TOPIC;
PEPTIDES;
RECOMBINANT PROTEINS;
UNITED STATES;
|
|
EID: 84865691230
PISSN: None
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0512-377 Document Type: Note |
|
Times cited : (2)
|
|
References (0)
|
